Legal cannabis doesn't spike teen hospitalizations for addiction

Nonmedical cannabis legalization and adolescent inpatient cannabis use disorder, 2008-2020: A quasi-experimental analysis.

The International journal on drug policy • • Moderately Relevant
🤖

AI Summary

This large-scale study examined whether legalizing recreational cannabis at the state level increased hospitalizations of adolescents (ages 10-17) diagnosed with cannabis use disorder (CUD) between 2008 and 2020. Researchers analyzed over 2.8 million inpatient discharge records across 13 U.S. states with different legalization timelines, using advanced statistical methods to account for differences between states. The key finding: legalization was not associated with a statistically significant increase in adolescent CUD-related hospitalizations overall, with only a 0.51 percentage point rise observed when comparing before and after legalization periods.

The study did find one notable exception—a statistically significant increase in hospitalized CUD cases appeared in year seven after legalization in the earliest-adopting states, though this pattern didn't hold consistently across states that legalized later. The researchers tested multiple scenarios, including measuring effects from when dispensaries actually opened versus legalization dates, and the overall conclusion remained robust: no clear link between legalization and adolescent CUD hospitalizations emerged across the full observation period. Importantly, no significant differences were found when analyzing by sex, age, race/ethnicity, or urban versus rural location.

While these findings suggest legalization hasn't driven a dramatic spike in adolescent cannabis use disorder severe enough to require hospitalization, researchers emphasized that longer follow-up periods may reveal delayed effects, and the data doesn't account for milder cases treated outside hospitals. The results contribute important evidence to the ongoing debate about legalization's health impacts on young people, showing that at least for severe, hospitalization-level cannabis use disorder, the fears of an immediate adolescent CUD epidemic haven't materialized."

📄 Original Abstract

Evidence on the impact of nonmedical cannabis legalization on adolescent cannabis use disorder (CUD) is inconsistent, with limited data on inpatient encounters. This study assesses whether state nonmedical cannabis legalization is related to inpatient discharges for adolescent CUD. We used a quasi-experimental design with generalized synthetic control and interactive fixed effects applied to annual state-level aggregates from 2,861,324 inpatient discharge records for adolescents aged 10-17 years across 13 U.S. states (2008-2020) with staggered legalization timelines. The primary outcome was a CUD diagnosis (ICD-9/ICD-10 codes) in any discharge position. Sensitivity analyses incorporated dispensary opening dates and subgroup stratification. Legalization was not associated with a statistically significant change in adolescent CUD-coded inpatient discharges (average treatment effect on the treated [ATT] = 0.0051; equivalent to a 0.51 percentage point increase; 95% CI, -0.0059-0.0160). Dynamic estimates showed no changes in the first six years post-legalization, but a statistically significant increase was observed in year seven (ATT = 0.0251; 95% CI, 0.0011-0.0491), driven by the earliest policy adopters. No consistent effects were found across later-adopting states. Results were robust to alternative specifications, including dispensary-based exposure timing (ATT = 0.0081; 95% CI, -0.003- 0.0194) and individual-level models. Stratified analyses by sex, age, race/ethnicity, and urbanicity showed no statistically significant associations. Findings did not detect a statistically significant overall association between state nonmedical cannabis legalization and adolescent CUD-coded inpatient discharges. Estimates from the observed follow-up were consistent with no statistically detectable association, though potential delayed or cohort-specific effects cannot be ruled out.

Explore More Research

Stay informed about the latest cannabis science.

Your stash, decoded.